Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance.

Karlyn A Martin, Craig R Lee, Timothy M Farrell, Stephan Moll

Journal: The American journal of medicine 2017;130(5):517-524

PMID: 28159600

Abstract

Bariatric surgery may alter the absorption, distribution, metabolism, or elimination (disposition) of orally administered drugs via changes to the gastrointestinal tract anatomy, body weight, and adipose tissue composition. As some patients who have undergone bariatric surgery will need therapeutic anticoagulation for various indications, appropriate knowledge is needed regarding anticoagulant drug disposition and resulting efficacy and safety in this population. We review general considerations about oral drug disposition in patients after bariatric surgery, as well as existing literature on oral anticoagulation after bariatric surgery. Overall, available evidence on therapeutic anticoagulation is very limited, and individual drug studies are necessary to learn how to safely and effectively use the direct oral anticoagulants. Given the sparsity of currently available data, it appears most prudent to use warfarin with international normalized ratio monitoring, and not direct oral anticoagulants, when full-dose anticoagulation is needed after bariatric surgery.

Copyright © 2017 Elsevier Inc. All rights reserved.

Address: Division of Hematology/Oncology, University of North Carolina at Chapel Hill. Electronic address: [email protected].; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.; Division of Gastrointestinal Surgery, University of North Carolina at Chapel Hill.; Division of Hematology/Oncology, University of North Carolina at Chapel Hill.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.